Mr Oladigbolu said that the GSK exit would further contribute to the unemployment rate in the country.
Some Abuja traders have urged President Muhammadu Buhari’s regime to provide a conducive environment for their businesses to thrive.
The pharmaceutical company on Thursday said that further tests will be carried out on the Sotrovimab therapy to firm up the results.
The WHO announced the approval in a statement on Wednesday.
The nation’s bourse returned to the positive territory on Thursday, rebounding by N15 billion following gains posted by FBN Holdings just as Nigeria’s GDP expanded.
A first administration of the vaccine among 48 trialists returned a 97 per cent success, according to the EPR report.
